YONGIN, South Korea, May 30, 2025 /PRNewswire/ -- GC Biopharma, a South Korean pharmaceutical company, announced that the Phase 3 clinical trial results for Hunterase (idursulfase beta), its investigational drug for Hunter Syndrome (MPS II), have been published in Genetics in Medicine, an...
Hence then, the article about gc biopharma s phase 3 clinical trial results for hunterase published in scie indexed journal was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( GC Biopharma's Phase 3 Clinical Trial Results for Hunterase Published in SCIE-Indexed Journal )
Also on site :
- 12-year old Russian beats world chess champion
- Hundreds of popular grocery, drug-store items recalled due to ‘filth' at Midwest distribution center
- Body recovered from Lake Natoma amid search for missing man